ReviewArchives of orthopaedic and trauma surgery2026
Vancouver B3 periprosthetic fractures of the femur: options for treatment.
Review in Archives of orthopaedic and trauma surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Vancouver B3 type periprosthetic fracture is a rare but difficult-to-treat complication of hip arthroplasty. Various options for the treatment of Vancouver B3 periprosthetic fractures are described in the medical literature. The problem with many studies is the small number of cases, the fact that the results of Vancouver B2 and B3 fractures are only presented together, the lack of a clear definition of B3 fractures and the resulting subjective categorisation of fractures into the two groups (Vancouver B2 and B3). Therefore, the evidence in the literature for the recommendation of treatment strategies for Vancouver B3 fractures can be classified as poor. This review aims to analyse the various therapeutic options with regard to the current state of knowledge based on reports of case series.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.